Virtual Event Coverage

Inaugural EF Hutton Global Conference

May 10-11, 2023 - The Plaza, New York - 5th Avenue at Central Park
EF Hutton Global Conference

The Inaugural EF Hutton Global Conference is a two-day, invitation-only event featuring key executives from approximately 150 public and private companies to convey their unique stories to an extensive audience that includes institutional investors, high-net worth individuals, corporate clients and exclusive members of the press.

Conference Website

Presenting Companies: A - L M - Z

22nd Century Group, Inc. (NASDAQ: XXII)

22nd Century Group, Inc. (NASDAQ: XXII) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the FDA's Comprehensive Plan to address the widespread death and disease caused by smoking. The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits. For more information visit the company's website at:

ACER Therapeutics (NASDAQ: ACER)

ACER Therapeutics (NASDAQ: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. In the U.S., OLPRUVA™ (sodium phenylbutyrate) is approved for the treatment of urea cycle disorders (UCDs) involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS). Acer is also advancing a pipeline of investigational product candidates for rare and life-threatening diseases, including: OLPRUVA™ (sodium phenylbutyrate) for the treatment of various disorders, including Maple Syrup Urine Disease (MSUD); ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms (iVMS), Post-traumatic Stress Disorder (PTSD) and prostate cancer; EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, Zika, dengue, Ebola and COVID-19. For more information, visit the company's website at:


AERWINS Technologies (NASDAQ: AWIN), an integrated Air Mobility company with the innovative vehicle XTURISMO and software like the C.O.S.M.O.S., smartphone applications and a sky visualization software, is not only envisioning, but addressing the future of the Air Mobility society. For more information, visit the company's website at:

Agenus Inc. (NASDAQ: AGEN)

Agenus Inc. (NASDAQ: AGEN) is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer and infections. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its subsidiary MiNK Therapeutics), and adjuvants (through its subsidiary SaponiQx). The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA. For more information, visit the company's website at:


Agilyx ASA (OSE: AGLX) (OTCQX: AGXXF) is a technology company that enables customers to recycle difficult-to-recycle post-use plastics to high value, virgin-equivalent products. With a focus on diversion and conversion of plastic waste, Agilyx is uniquely positioned with a molecular recycling technology offering and an integrated feedstock solution by way of Cyclyx, an innovative feedstock management consortium of partners that drives up global plastic recycling rates by chemically fingerprinting plastic waste and matching it to appropriate recycling processes. Agilyx was the first to establish a commercial scale closed loop plastic-to-plastic chemical recycling facility and holds over 17 patents. Agilyx conversion technology utilizes pyrolysis without a catalyst and can convert mixed waste plastic to naphtha and fuels or depolymerize specific plastics such as polystyrene and PMMA (acrylic) back into virgin-quality products. For more information, visit the company's website at:

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI; AGRIW)

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI; AGRIW) is an agtech company focused on building an integrated agtech platform that combines the best technology, intellectual property, and knowledge to solve an urgent problem – providing the best solutions to help drive sustainable crops and nutritious food for people around the world. The AgriFORCE vision is to be a global leader in delivering plant-based foods and products through an advanced and sustainable agtech platform that makes positive change in the world—from seed to table. For more information, visit the company's website at:

Agrify Corporation (NASDAQ: AGFY)

Agrify Corporation (NASDAQ: AGFY) is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Their proprietary micro-environment-controlled Vertical Farming Units (VFUs) enable cultivators to produce the highest quality products with unmatched consistency, yield, and ROI at scale. Their comprehensive extraction product line, which includes hydrocarbon, ethanol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates. For more information, visit the company's website at:

Alamo Group Inc. (NYSE: ALG)

Alamo Group (NYSE: ALG) is a leader in the design, manufacture, distribution and service of high- quality equipment for vegetation management, infrastructure maintenance and other applications. Their products include truck and tractor mounted mowing and other vegetation maintenance equipment, street sweepers, snow removal equipment, excavators, vacuum trucks, other industrial equipment, agricultural implements, forestry equipment and related after-market parts and services. The Company, founded in 1969, has approximately 4,200 employees and operates 29 plants in North America, Europe, Australia and Brazil. The corporate offices of Alamo Group Inc. are located in Seguin, Texas. For more information, visit the company's website at:

American Rebel Holdings, Inc. (NASDAQ: AREB)

American Rebel Holdings, Inc. (NASDAQ: AREB) - America's Patriotic Brand - is a lifestyle brand that designs, manufactures and sells its flagship full-size safes as well as its concealed carry backpacks and apparel and associated accessories. American Rebel is introducing several new products at the 2023 SHOT Show in Las Vegas, including 2A Lockers and a new line of American Rebel branded E-Bikes. For more information, visit the company's website at:

American Resources Corporation (NASDAQ: AREC)

American Resources Corporation (NASDAQ: AREC) is a next-generation, environmentally and socially responsible supplier of high-quality raw materials to the new infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. Through its wholly owned subsidiary, ReElement Technologies, American Resources is redefining how critical and rare earth elements are both sourced and processed while focusing on the recycling of end-of-life products such as rare earth permanent magnets and lithium-ion batteries, as well as coal-based waste streams and byproducts. American Resources has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon and rare earth mineral deposits are concentrated. American Resources has established a nimble, low-cost business model centered on growth, which provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets while also continuing to acquire operations and significantly reduce their legacy industry risks. Its streamlined and efficient operations are able to maximize margins while reducing costs. For more information, visit the company's website at:

American Superconductor Corporation (NASDAQ: AMSC)

American Superconductor Corporation (NASDAQ: AMSC) generates the ideas, technologies and solutions that meet the world's demand for smarter, cleaner … better energy™. Through its Gridtec™ Solutions, AMSC provides the engineering planning services and advanced grid systems that optimize network reliability, efficiency and performance. Through its Marinetec™ Solutions, AMSC provides ship protection systems and is developing propulsion and power management solutions designed to help fleets increase system efficiencies, enhance power quality and boost operational safety. Through its Windtec™ Solutions, AMSC provides wind turbine electronic controls and systems, designs and engineering services that reduce the cost of wind energy. The Company's solutions are enhancing the performance and reliability of power networks, increasing the operational safety of navy fleets, and powering gigawatts of renewable energy globally. Founded in 1987, AMSC is headquartered near Boston, Massachusetts with operations in Asia, Australia, Europe and North America. For more information, visit the company's website at:


AMMO, Inc. (NASDAQ: POWW) is headquartered in Scottsdale, Arizona. AMMO designs and manufactures products for a variety of aptitudes, including law enforcement, military, sport shooting and self-defense. The Company was founded in 2016 with a vision to change, innovate and invigorate the complacent munitions industry. AMMO promotes branded munitions as well as its patented STREAK™ Visual Ammunition, /stelTH/™subsonic munitions, and armor piercing rounds for military use. For more information visit the company's website at:

Amprius Technologies (NYSE: AMPX)

Amprius Technologies (NYSE: AMPX) is a leading manufacturer of high-energy and high-capacity lithium-ion batteries producing the industry's highest energy density cells. The company's corporate headquarters is in Fremont, California, where it maintains an R&D lab and a pilot manufacturing facility for the fabrication of silicon nanowire anodes and cells. For more information visit the company's website at:

Apollomics Inc. (NASDAQ: APLM)

Apollomics Inc. (NASDAQ: APLM) is an innovative biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. For more information visit the company's website at:

Applied UV, Inc. (NASDAQ: AUVI)

Applied UV, Inc. (NASDAQ: AUVI) develops and acquires proprietary infection prevention and control technology in the healthcare, commercial & public venue, food processing/storage, cannabis, and education, vertical markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen owns and markets a portfolio of products with advanced pathogen elimination technology, branded Airocide ® by SteriLumen, Scientific Air™ by SteriLumen, Airoclean™ 420 by SteriLumen, and Lumicide™ by SteriLumen. The Company's acquisition of Puro Lighting, LLC adds a powerful monitoring software platform that opens new opportunities to inter-connect its portfolio of UV technology solutions. The platform has the potential to elevate Applied UV's offerings into the IoT space by providing its customers with both products and smart tools to manage and monitor indoor air quality across an enterprise. For more information visit the company's website at:

AppTech Payments Corp. (NASDAQ: APCX)

AppTech Payments Corp. (NASDAQ: APCX) is an innovative Fintech company whose mission is to deliver a better way for businesses to provide their customers with immersive commerce experiences. Commerse™, its all-new, patent-backed technology platform powering seamless omni-channel Commerce Experiences-as-a-Service (CXS), drives highly secure, scalable, cross-border digital banking, text-to-pay, and merchant services altogether from a single, unified stack designed to increase operational efficiencies and growth for businesses while providing the economic convenience that their customers demand from today's commerce experiences. For more information visit the company's website at:

Atlas Lithium Corporation (NASDAQ: ATLX)

Atlas Lithium Corporation (NASDAQ: ATLX) is focused on advancing and developing its 100%-owned hard-rock lithium project which consists of 57 mineral rights spread over approximately 58,774 acres (238 km2) and is located primarily in the municipality of Araçuaí in the Lithium Valley of the state of Minas Gerais in Brazil. Atlas Lithium also has a separate second lithium project located in Brazil's Northeast region. In total, Atlas Lithium has 100% ownership of mineral rights for almost all battery metals including lithium (304 km2), nickel (222 km2), rare earths (122 km2), titanium (89 km2), and graphite (56 km2), in addition to mining concessions for gold, diamonds, and sand. The Company also owns approximately 45% of Apollo Resources Corp. (private company; iron) and approximately 28% of Jupiter Gold Corp. (OTCQB: JUPGF; gold and quartzite). For more information visit the company's website at:

AUM Biosciences

AUM Biosciences is a global clinical stage biotech company, focused on discovering, developing, and advancing novel targeted pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance, particularly for cancers with a clear genetic-markers and "undruggable targets." They employ a comprehensive drug development approach (asset selection / global clinical execution) focused on targeting Intracellular pathways overcoming drug resistance, and select indications where they can leverage accelerated regulatory approvals (e.g., Orphan Drugs / Pediatric cancers). In addition, AUM seeks to achieve clinical proof-of-concept via combination treatment regimens internally (intra-portfolio) and externally with strategic partners. On October 20, 2022, AUM announced it was entering into a merger agreement with Mountain Crest Acquisition Corporation V, a Special Purpose Acquisition Corporation (SPAC), subject to obtaining the requisite approvals. The transaction, expected to close in January of 2023, would increase AUM's profile and access to capital for further advancing the company's pipeline through major milestones attractive to targeted investors. For more information visit the company's website at:

Biomea Fusion, Inc. (NASDAQ: BMEA)

Biomea Fusion, Inc. (NASDAQ: BMEA) is a clinical stage biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with genetically defined cancers and metabolic diseases. A covalent small molecule is a synthetic compound that forms a permanent bond to its target and offers a number of potential advantages over conventional non-covalent drugs, including greater target selectivity, lower drug exposure, and the ability to drive a deeper, more durable response. The company is utilizing its proprietary FUSION™ System to discover, design and develop a pipeline of next-generation covalent-binding small molecule medicines designed to target key drivers of cancer and metabolic diseases, including diabetes. Biomea Fusion is a leader in advancing next-generation covalent small molecule medicines. Biomea aims to cure. For more information visit the company's website at:

BioRestorative Therapies, Inc. (NASDAQ: BRTX)

BioRestorative Therapies, Inc. (NASDAQ: BRTX) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Their two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders. Disc/Spine Program (brtxDISC™): Their lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. They intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. The BRTX-100 production process utilizes proprietary technology and involves collecting a patient's bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient's damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. They have received authorization from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. Metabolic Program (ThermoStem ®): They are developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue ("BAT"). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in animals may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels. For more information visit the company's website at:

BioVie Inc. (NASDAQ: BIVI)

BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative therapies to overcome unmet medical needs in chronic debilitating conditions. In neurodegenerative disease, the Company's drug candidate NE3107 inhibits inflammatory activation of ERK and NFkB (e.g., TNF signaling) that leads to neuroinflammation and insulin resistance, but not their homeostatic functions (e.g., insulin signaling and neuron growth and survival). Both are drivers of Alzheimer's and Parkinson's diseases. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients with mild to moderate Alzheimer's disease (NCT04669028) and is targeting primary completion in 3rd quarter of 2023. An estimated six million Americans suffer from Alzheimer's. A Phase 2 study of NE3107 in Parkinson's disease (NCT05083260) has completed and provided its topline data readout in December 2022. In liver disease, the Company's Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated in a US Phase 2b study for the treatment of refractory ascites due to liver cirrhosis with top-line results anticipated in mid-2023. BIV201 is administered as a patent-pending liquid formulation. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis. For more information, visit the company's website at:

BK Technologies Corp. (AMEX: BKTI)

BK Technologies Corp. (AMEX: BKTI) manufactures high-specification, American-made communications equipment of unsurpassed reliability and value for use by public safety professionals and government agencies. BK Technologies is honored to serve these heroes with reliable equipment when every moment counts. The Company's common stock trades on the NYSE American market under the symbol "BKTI". For more information visit the company's website at:

Blue Star Foods Corp. (NASDAQ: BSFC)

Blue Star Foods Corp. (NASDAQ: BSFC) is an integrated Environmental, Social, and Governance (ESG) sustainable seafood company with a focus on Recirculatory Aquaculture Systems (RAS) that processes, packages and sells high-value seafood products. The Company believes it utilizes best-in-class technology, in both resource sustainability management and traceability, and ecological packaging. The Company also owns and operates the oldest continuously operating Recirculating Aquaculture System (RAS) full grow-out salmon farm in North America. The company is based in Miami, Florida. For more information visit the company's website at:

Bone Biologics Corporation (NASDAQ: BBLG)

Bone Biologics Corporation (NASDAQ: BBLG) is focusing current development efforts for its bone graft substitute product on bone regeneration in spinal fusion, and also holds technology rights to trauma and osteoporosis indications. For more information visit the company's website at:

BurgerFi International, Inc. (NASDAQ: BFI)

BurgerFi International, Inc. (NASDAQ: BFI) is a leading multi-brand restaurant company that develops, markets, and acquires fast-casual and premium-casual dining restaurant concepts around the world, including corporate-owned stores and franchises. BurgerFi is among the nation's fastest-growing better burger concepts with 114 BurgerFi restaurants (89 franchised and 25 corporate-owned). As of the Company's fiscal year ended January 2, 2023, BurgerFi is the owner and franchisor of the two following brands with a combined 174 locations. For more information visit the company's website at:

Cantargia AB (NASDAQ: CANTA)

Cantargia AB (NASDAQ: CANTA) is a clinical stage antibody development company focusing on the opportunities on the novel target IL1RAP. Lead asset nadunolimab in phase 2 development in pancreatic cancer, non-small cell lung cancer and triple negative breast cancer. Positive interim results have been presented in all these indications. Second asset, CAN10 entering phase I, developed against myocarditis and systemic sclerosis. For more information visit the company's website at:

CareCloud, Inc. (NASDAQ: CCLD, CCLDO)

CareCloud (NASDAQ: CCLD, CCLDO) is a leading provider of technology-enabled services and solutions that redefine the healthcare revenue cycle. They provide technology-enabled revenue cycle management and a full suite of proprietary cloud-based solutions to healthcare providers, from small practices to enterprise medical groups, hospitals, and health systems, throughout the United States. Healthcare organizations today operate in highly complex and regulated environments. Their suite of technology-enabled solutions helps their clients increase financial and operational performance, streamline clinical workflows, and improve the patient experience. For more information visit the company's website at:

CEL-SCI Corporation (NYSE American: CVM)

CEL-SCI Corporation (NYSE American: CVM) is a clinical-stage biotechnology company focused on finding the best way to activate the immune system to fight cancer and infectious diseases. CEL-SCI completed the world's largest Phase 3 study in head and neck cancer and reported data showing a significant survival benefit with no toxicity added in patients with advanced primary squamous cell carcinoma of the head and neck (SCCHN) who received its Multikine® immunotherapy prior to a standard of care (SOC) treatment of surgery plus radiotherapy as compared to patients who received SOC alone. Multikine reduced and eliminated tumors within 3 weeks and before surgery. CEL-SCI is preparing to file for regulatory approval through a Biologic License Application (BLA) with the U.S. Food and Drug Administration (FDA) for a patient population comprising over 200,000 annually. CEL-SCI's goal is to have the greatest impact by activating the immune system to fight cancer BEFORE surgery and radiation have damaged it, addressing the largest segment of the market—people with newly diagnosed cancer. Head and neck cancer is a multi-billion dollar global market and Multikine has received Orphan Drug designation from the FDA for this indication, SCCHN, an unmet need for which the FDA has not approved a new treatment in over 50 years. CEL-SCI has completed the commercial scale buildout of its Multikine manufacturing facility in anticipation of market demand for Multikine once it receives regulatory approval. For more information visit the company's website at:

Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)

Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) is a market-leading mortgage REIT utilizing significant real estate, credit and cannabis expertise to originate senior secured loans primarily to state-licensed cannabis operators in limited-license states in the United States. For more information visit the company's website at:

Cinedigm Corp. (NASDAQ: CIDM)

Cinedigm (NASDAQ: CIDM) has led the digital transformation of the entertainment industry for over 20 years. Today, Cinedigm entertains consumers around the globe by providing premium feature film and television series, enthusiast streaming channels and technology services to the world's largest media, retail, and technology companies. As a leader in the streaming industry, Cinedigm continues its legacy as an innovator through its adoption of next-generation technologies, such as artificial intelligence and machine learning, through its proprietary, highly scalable Matchpoint® technology platform. For more information, visit the company's website at:

Compass Therapeutics, Inc. (NASDAQ: CMPX)

Compass Therapeutics, Inc. (NASDAQ: CMPX) is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass's pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. Compass was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the company's website at:

Core Molding Technologies, Inc. (NYSE American: CMT)

Core Molding Technologies, Inc. (NYSE American: CMT) is a leading engineered materials company specializing in molded structural products, principally in building products, utilities, transportation and powersports industries across North America. For more information, visit the company's website at:

CoreCard Corporation (NYSE: CCRD)

CoreCard Corporation (NYSE: CCRD) provides a pioneering card management platform built for the future of global transactions in a digital world. Dedicated to continual technological innovation in the ever-evolving payments industry backed by decades of deep expertise in credit card offerings, CoreCard helps customers conceptualize, implement, and manage all aspects of their issuing card programs. Keenly focused on steady, sustainable growth, CoreCard has earned the trust of some of the largest companies and financial institutions in the world, providing truly real-time transactions via their proven, reliable platform operating on private on-premise and leading cloud technology infrastructure. For more information, visit the company's website at:

Creative Media & Community Trust Corporation (NASDAQ: CMCT)

Creative Media & Community Trust Corporation (NASDAQ: CMCT) is a real estate investment trust that seeks to own, operate and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. CMCT is a leader in creative office, acquiring and developing properties catering to rapidly growing industries such as technology, media and entertainment. CMCT seeks to apply the expertise of CIM to the acquisition, development, and operation of top-tier multifamily properties situated in dynamic markets with similar business and employment characteristics to its creative office investments. CMCT also owns one hotel in Northern California and a lending platform that originates loans under the Small Business Administration ("SBA")'s 7(a) loan program. CMCT is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities. For more information, visit the company's website at:

CTO Realty Growth, Inc. (NYSE: CTO)

CTO Realty Growth, Inc. (NYSE: CTO) is a publicly traded real estate investment trust that owns and operates a portfolio of high-quality, retail-based properties located primarily in higher growth markets in the United States. CTO also externally manages and owns a meaningful interest in Alpine Income Property Trust, Inc. (NYSE: PINE), a publicly traded net lease REIT. For more information, visit the company's website at:

Digital Ally, Inc. (NASDAQ: DGLY)

Digital Ally, Inc. (NASDAQ: DGLY), through its subsidiaries, is engaged in video solution technology, human & animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, event production and jet chartering. Digital Ally continues to add organizations that demonstrate the common traits of positive earnings, growth potential, innovation and organizational synergies. For more information, visit the company's website at:

Dolphin Entertainment, Inc. (NASDAQ: DLPN)

Dolphin Entertainment, Inc. (NASDAQ: DLPN) is a leading independent entertainment marketing and production company. Through their subsidiaries 42West, The Door, Shore Fire Media and B/HI (a division of 42West), they provide expert strategic marketing and publicity services to many of the top brands, both individual and corporate, in the film, television, music, gaming and hospitality industries. All three PR firms have been ranked among the most recent Observer's "Power 50" PR Firms in the United States. Viewpoint Creative, Be Social and Socialyte complement their efforts with full-service creative branding and production capabilities as well as social media and influencer marketing services. Dolphin's legacy content production business, founded by Emmy-nominated CEO Bill O'Dowd, has produced multiple feature films and award-winning digital series, and has recently entered into a multi-year agreement with IMAX to co-produce feature documentaries. For more information, visit the company's website at:

Electromed, Inc. (NYSE American: ELMD)

Electromed, Inc. (NYSE American: ELMD) manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. For more information, visit the company's website at:

Electrovaya Inc. (TSX: EFL) (OTCQB: EFLVF)

Electrovaya Inc. (TSX: EFL) (OTCQB: EFLVF) is a pioneering leader in the global energy transformation, focused on contributing to the prevention of climate change by supplying safe and long-lasting lithium-ion batteries without compromising energy and power. Electrovaya is a technology-focused company with extensive IP, designs, develops, and manufactures proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications. Company's Infinity line of batteries is focused on commercial vehicles and its Solid State Technology under Development is focused on passenger vehicles. For more information, visit the company's website at:

Enovix Corporation (NASDAQ: ENVX)

Enovix Corporation (NASDAQ: ENVX) is on a mission to power the technologies of the future. Everything from IoT, mobile and computing devices, to the vehicle you drive, needs a better battery. The company's disruptive architecture enables a battery with high energy density and capacity without compromising safety. Enovix is scaling its silicon-anode, lithium-ion battery manufacturing capabilities to meet customer demand. For more information, visit the company's website at:

Entravision Communications Corporation (NYSE: EVC)

Entravision Communications Corporation (NYSE: EVC) is a leading global advertising, media and ad-tech solutions company connecting brands to consumers by representing top platforms and publishers. Their dynamic portfolio includes digital, television and audio offerings. Digital, their largest revenue segment, is comprised of four business units: their digital sales representation business; Smadex, their programmatic ad purchasing platform; their branding and mobile performance solutions business; and their digital audio business. Through their digital sales representation business, they connect global media companies such as Meta, Twitter, TikTok and Spotify with advertisers in primarily emerging growth markets worldwide. Smadex is their mobile-first demand side platform, enabling advertisers to execute performance campaigns using machine learning. They also offer a branding and mobile performance solutions business, which provides managed services to advertisers looking to connect with global consumers, primarily on mobile devices, and their digital audio business provides digital audio advertising solutions for advertisers in the Americas. In addition to digital, Entravision has 49 television stations and is the largest affiliate group of the Univision and UniMás television networks. Entravision also manages 45 primarily Spanish-language radio stations that feature nationally recognized, Emmy award-winning talent. For more information, visit the company's website at:

Fiesta Restaurant Group, Inc. (NASDAQ: FRGI)

Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) owns, operates and franchises the Pollo Tropical® fast-casual restaurant brand. The brand features fresh-made cooking, offering distinct and unique flavors with broad appeal at a compelling value through dine-in service, drive-thru service and catering. For more information, visit the company's website at:

FingerMotion, Inc. (NASDAQ: FNGR)

A bleeding-edge mobile data and technology company, FingerMotion (NASDAQ: FNGR) is focused on improving people's lifestyle through technology and innovation by understanding human behavior. For more information, visit the company's website at:

Fiscalnote Holdings, Inc. (NYSE: NOTE)

Fiscalnote Holdings, Inc. (NYSE: NOTE) is focused on empowering organizations with mission-critical insights and the tools to turn them into action. FiscalNote is the leading technology provider of global policy and market intelligence. By uniquely combining AI technology, actionable data, and expert and peer insights, FiscalNote empowers customers with mission-critical insights and the tools to turn them into action. Home to CQ, FrontierView, Oxford Analytica, VoterVoice, and many other industry-leading brands, FiscalNote helps organizations stay ahead of rapidly evolving political, corporate, and regulatory environments. For more information visit the company's website at:

Flow Beverage Corp. (OTC: FLWBF)

Flow Beverage Corp. (OTC: FLWBF) is a premium alkaline spring water company with a diversified line of health and wellness-oriented beverage products sold online and at retailers throughout North America. Flow's premium alkaline spring water is offered in original unflavored and a range of award-winning organic flavors, in sizes ranging from 330-ml to 1-liter. Due to its unique artesian spring sources, Flow products contain naturally occurring electrolytes and essential minerals, and its original and flavored water products have an alkaline pH. As part of its ongoing innovation into functional "better-for-you" beverages, Flow recently introduced a new line of collagen-infused waters with natural flavors. Founded in 2014 by serial, mission-driven entrepreneur Nicholas Reichenbach, Flow is highly dedicated to sustainability and is a B-Corp Certified company with a purpose to "bring wellness to the world through the positive power of water." Flow set out to be a sustainable brand, packaging its products in up to 75% renewable-resource-based Tetra Pak™ cartons utilizing sustainable operations. For more information visit the company's website at:

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX)

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the Company's wholly owned subsidiaries, Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both "in-line-of-sight" vision systems and "beyond-line-of-sight" accident-prevention solutions. Foresight's vision solutions include modules of automatic calibration and dense three-dimensional (3D) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile's cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information visit the company's website at:

Gaucho Group Holdings, Inc. (NASDAQ: VINO)

Gaucho Group Holdings, Inc. (NASDAQ: VINO) is a rapidly growing, e-commerce driven public holding company that has built from the ground up, and currently operates, a portfolio of experiential luxury brands and real estate assets. Their businesses lay in leading market sectors with a reputation for excellence including e-commerce direct to consumer Fine Wines, Leather Accessories & Fashion, as well as hospitality and experiential projects such as Luxury Boutique Hotels and a 4,138 acre Luxury Vineyard Real Estate development. Though each of their businesses can stand alone as a breakout brand with its own unique identity, products and loyal consumers, one of the greatest strengths of Gaucho Holdings' integrated business model is that their joint resources allow them to streamline operations across platforms such as creative and marketing, accounting, sourcing, fulfillment and other logistics, which are then shared across their businesses to the advantage of all. Gaucho Holdings' carefully curated assemblage of exciting, emerging brands – when viewed collectively – form an even greater whole that is truly exceptional. For more information visit the company's website at:

Genasys (NASDAQ: GNSS)

Genasys® (NASDAQ: GNSS) is a global provider of critical communications systems and solutions that help keep people safe. Genasys' unified multichannel platform empowers governments and businesses to deliver real-time geo-targeted alerts, notifications, instructions, and information before, during, and after public safety and enterprise threats. For more information visit the company's website at:

Generation Income Properties, Inc. (NASDAQ: GIPR)

Generation Income Properties, Inc. (NASDAQ: GIPR), located in Tampa, Florida, is an internally managed real estate investment trust formed to acquire and own, directly and jointly, real estate investments focused on retail, office and industrial net lease properties located primarily in densely populated submarkets throughout the United States. For more information visit the company's website at:

Graphex Technologies, LLC (NYSE American: GRFX)

Graphex Technologies, LLC (NYSE American: GRFX), a global leader in mid-stream processing of natural graphite for use in EV batteries and other power use applications such as energy storage and electronics, is a Cayman Island company with principal and administrative offices in Hong Kong and subsidiary office in Royal Oak, MI. Proficient in commercial deep processing of graphite, Graphex has been consistently producing over 10,000 metric tons of spherical graphite annually for over 9 years. For more information visit the company's website at:

Guardforce AI Co., Ltd. (NASDAQ: GFAI, GFAIW)

Guardforce AI Co., Ltd. (NASDAQ: GFAI, GFAIW) is a global security solutions provider, building on its legacy secured logistic business while expanding and transforming into an integrated AI and Robot-as-a-Service (RaaS) business. With more than 40 years of professional experience and a strong customer foundation, Guardforce AI is developing RaaS solutions that improve operational efficiency, quickly establishing its presence in the Asia Pacific region, while expanding globally. For more information visit the company's website at:

HCW Biologics, Inc. (NASDAQ: HCWB)

HCW Biologics Inc. (NASDAQ: HCWB) is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The Company believes age-related low-grade chronic inflammation, or "inflammaging," is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. For more information visit the company's website at:

HeartSciences (NASDAQ: HSCS)

HeartSciences (NASDAQ: HSCS) sits at the forefront of innovation and technological development focused on advancing the field of electrocardiology to provide early heart disease detection. Its first product, the MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device, is a resting 12-lead electrocardiograph that uses AI and continuous wavelet transform (CWT) signal processing to provide cardiac information associated with left ventricular diastolic dysfunction (LVDD), a condition which has previously not been possible to detect using conventional electrocardiology. LVDD is associated with almost all forms and co-morbidities of heart disease and may include hypertension, diabetes, valvular disease, ischemia, and reduced systolic function, among others. The MyoVista Device additionally provides all the information and capabilities of a full-featured conventional resting 12-lead ECG within the same test and follows the same clinical AHA/IEC lead placement protocol. HeartSciences is based in Southlake, Texas. The MyoVista Device is not currently FDA cleared and is not available in the United States. For more information visit the company's website at:

Hoth Therapeutics, Inc. (NASDAQ: HOTH)

Hoth Therapeutics, Inc. (NASDAQ: HOTH) is a clinical-stage biopharmaceutical company dedicated to developing innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. They are a catalyst in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, they collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate medications that hold immense potential to create breakthroughs and diversify treatment options. For more information visit the company's website at:

Hudson Technologies, Inc. (NASDAQ: HDSN)

Hudson Technologies, Inc. (NASDAQ: HDSN) focuses their full attention on refrigerants and how they impact chiller performance. From refrigerant sales and reclamation services to on-site problem solving and energy-saving assessments, they lead the way in ensuring that your systems operate at peak performance. They support the circular economy for refrigerants and their commitment to environmental stewardship is core to everything they do. Hudson has proven, reliable programs that meet your sustainability needs. From initial sale through recovery, reclamation and reuse, peak operating performance of equipment through energy efficiency and emergency HVAC system repair, to CFC refrigerant disposal and carbon credit development they provide environmentally sustainable solutions to your refrigerant needs. And with multiple reclamation facilities through the U.S., they have the infrastructure to make refrigerant reclamation as easy as possible. If your needs are as simple as buying or selling refrigerants, they do so in whatever containers you need – from as small as 30 pounds to as large as a railcar. If your needs involve recycling (reclaiming refrigerants), they handle that too. They are the largest reclamation company in the country for a reason! For more information, visit the company's website at:

Hyster-Yale Materials Handling, Inc. (NYSE: HY)

Hyster-Yale Materials Handling, Inc. (NYSE: HY), headquartered in Cleveland, Ohio, offers a broad array of solutions to meet the specific materials handling needs of customers' applications. The Company's wholly owned operating subsidiary, Hyster-Yale Group, Inc., designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments and aftermarket parts marketed globally primarily under the Hyster® and Yale® brand names. Subsidiaries of Hyster-Yale include Bolzoni S.p.A., a leading worldwide producer of attachments, forks and lift tables marketed under the Bolzoni®, Auramo® and Meyer® brand names and Nuvera Fuel Cells, LLC, an alternative-power technology company focused on fuel cell stacks and engines. Hyster-Yale Group also has an unconsolidated joint venture in Japan (Sumitomo NACCO). For more information, visit the company's website at:

i(x) Net Zero PLC (AIM: IX)

i(x) Net Zero PLC (AIM: IX), the investing company which focusses on Energy Transition and Sustainability in the Built Environment, was founded in 2015 by Trevor Neilson, Pär Lindström and Howard W. Buffett. It provides its shareholders the opportunity to create long-term capital growth with positive, scalable, measurable and sustainable impact on the environment and on the communities it serves. They accomplish this by investing in sectors that are critical to solving humanity's most pressing issues, which i(x) Net Zero believes are also the biggest investment opportunities. As an investing company, i(x) Net Zero is intentionally designed to align the interests of its shareholders alongside investors who can deploy capital into their holdings directly. They share the common goal to produce top-tier, institutional quality returns and achieve measurable, scalable impact. The Company uses a multi-strategy investment approach, generally providing the companies in which it invests expertise and catalytic capital to help them grow. For more information, visit the company's website at:

Ideal Power, Inc. (NASDAQ: IPWR)

Ideal Power (NASDAQ: IPWR) is pioneering the development of its broadly patented bidirectional semiconductor power switch, creating highly efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS/data center, solid-state circuit breaker and other industrial and military applications. The Company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN™) semiconductor technology. B-TRAN™ is a unique double-sided bidirectional AC switch able to deliver substantial performance improvements over today's conventional power semiconductors. Ideal Power believes B-TRAN™ will reduce conduction and switching losses, complexity of thermal management and operating cost in medium voltage AC power switching and control circuitry. For more information, visit the Company's website at:

IDW Media Holdings, Inc. (NYSE American: IDW)

IDW Media Holdings, Inc. (NYSE American: IDW) is an integrated media company providing compelling stories and characters for global audiences. Their IDW Publishing and IDW Entertainment businesses acquire IP for holistic franchise development across comics and graphic novels, television and other entertainment platforms and leverage established stories from their creative partners. For more information visit the company's website at:

Innovative Solutions and Support, Inc. (NASDAQ: ISSC)

Innovative Solutions & Support Inc. (NASDAQ: ISSC) transforms leading edge technologies into sophisticated, cost-effective solutions for the Commercial Air Transport, Military, and Business Aviation Markets. Advanced functionality, enhanced situational awareness, reduced pilot workload, and improved safety are just some of the benefits found in their innovative solutions. For more information visit the company's website at:

Innoviva, Inc. (NASDAQ: INVA)

Innoviva, Inc. (NASDAQ: INVA) is a diversified holding company with a portfolio of royalties and other healthcare assets. Innoviva's royalty portfolio includes respiratory assets partnered with Glaxo Group Limited ("GSK"), including RELVAR®/BREO® ELLIPTA® (fluticasone furoate/ vilanterol, "FF/VI") and ANORO® ELLIPTA® (umeclidinium bromide/ vilanterol, "UMEC/VI"). Under the Long-Acting Beta2 Agonist ("LABA") Collaboration Agreement, Innoviva is entitled to receive royalties from GSK on sales of RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®. Innoviva's other healthcare assets include infectious disease and hospital assets stemming from acquisitions of Entasis Therapeutics Inc., including its lead asset sulbactam-durlobactam, and La Jolla Pharmaceutical Company, including GIAPREZA® (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock and XERAVA® (eravacycline) for the treatment of complicated intra-abdominal infections in adults. For more information visit the company's website at:


inTEST Corporation (NYSE AMERICAN: INTT) is a global supplier of innovative test and process technology solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. Backed by decades of engineering expertise and a culture of operational excellence, they solve difficult thermal, mechanical and electronic challenges for customers worldwide while generating strong cash flow and profits. Their strategy uses these strengths to grow and increase stockholder value by maximizing their businesses and by identifying, acquiring and optimizing complementary businesses. Headquartered in Mt. Laurel, New Jersey with four U.S. manufacturing locations and sales and service in seven countries. For more information visit the company's website at:

Iteris, Inc. (NASDAQ: ITI)

Iteris, Inc. (NASDAQ: ITI) is the world's trusted technology ecosystem for smart mobility infrastructure management. Delivered through Iteris' ClearMobility® Platform, their cloud-enabled end-to-end solutions monitor, visualize and optimize mobility infrastructure around the world, and help bridge legacy technology silos to unlock the future of transportation. That's why more than 10,000 public agencies and private-sector enterprises focused on mobility rely on Iteris every day. For more information visit the company's website at:

Jasper Therapeutics, Inc. (NASDASQ: JSPR)

Jasper Therapeutics (NASDAQ: JSPR) is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a therapeutic for chronic mast and stem cell diseases such as chronic spontaneous urticaria (CSU) and lower to intermediate risk myelodysplastic syndromes (MDS) and as a conditioning agent for stem cell transplants for rare diseases such as sickle cell disease (SCD), Fanconi anemia (FA) and severe combined immunodeficiency (SCID). To date, briquilimab has a demonstrated efficacy and safety profile in over 130 dosed subjects and healthy volunteers, with clinical outcomes as a conditioning agent in SCID, acute myeloid leukemia (AML), MDS, FA, and SCD. In addition, briquilimab is being advanced as a transformational non-genotoxic conditioning agent for gene therapy. For more information visit the company's website at:

Kidpik Corp. (NASDAQ: PIK)

KIDPIK (NASDAQ: PIK) is an online clothing subscription box for kids, offering mix & match, expertly styled outfits that are curated based on each member's style preferences. KIDPIK delivers a surprise box monthly or seasonally, providing an effortless shopping experience for parents and a fun discovery for kids. Each seasonal collection is designed in-house by a team with decades of experience designing childrenswear. KIDPIK combines the expertise of fashion stylists with proprietary data and technology to translate kids' unique style preferences into surprise boxes of curated outfits. For more information visit the company's website at:

Kimball Electronics, Inc. (NASDAQ: KE)

Kimball Electronics, Inc. (NASDAQ: KE) is a multifaceted manufacturing solutions provider of electronics and diversified contract manufacturing services to customers around the world. From their operations in the United States, China, India, Japan, Mexico, Poland, Romania, Thailand, and Vietnam, their teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, they are committed to a high-performance culture that values personal and organizational commitment to quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (Nasdaq: KE) is headquartered in Jasper, Indiana. For more information visit the company's website at:

Lantern Pharma Inc. (NASDAQ: LTRN)

Lantern Pharma Inc. (NASDAQ: LTRN) is a clinical stage biotechnology company focused on innovating the cancer drug development process by using advanced genomics, machine learning, and artificial intelligence ("A.I.").Their A.I. platform, known as RADR®️, currently includes more than 25 billion data points, and uses big data analytics and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then to identify the cancer patients that they believe may benefit most from their compounds. RADR®️ is also used by Lantern and its collaborators to 1) develop and position new drugs and 2) to rescue and reposition drug candidates that others have tried, but failed, to develop. Lantern's current portfolio consists of four drug candidates and an ADC program across twelve disclosed tumor targets, including two Phase 2 programs and several additional Phase 1 clinical trials anticipated for 2023. Lantern seeks out experienced industry partners, world-class scientific advisors and innovative clinical-regulatory approaches to assist with its objective of delivering cancer therapies to patients as quickly and cost-effectively as possible. For more information visit the company's website at:

Legacy Housing Corporation (NASDAQ: LEGN)

Legacy Housing Corporation (NASDAQ: LEGN) builds, sells, and finances manufactured homes and "tiny houses" that are distributed through a network of independent retailers and company-owned stores. The Company also sells directly to manufactured housing communities. Legacy is the sixth largest producer of manufactured homes in the United States as ranked by number of homes manufactured based on the information available from the Manufactured Housing Institute. With current operations focused primarily in the southern United States, they offer their customers an array of quality homes ranging in size from approximately 390 to 2,667 square feet consisting of 1 to 5 bedrooms, with 1 to 3 1/2 bathrooms. Their homes range in price, at retail, from approximately $22,000 to $140,000. For more information visit the company's website at:

Lexaria Bioscience Corp. (NASDAQ: LEXX)

Lexaria Bioscience Corp. (NASDAQ: LEXX)'s patented drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 28 patents granted and many patents pending worldwide. For more information visit the company's website at:

Liberty Resources Acquisition Corp. (NASDAQ: LIBY)

Liberty Resources Acquisition Corp. (NASDAQ: LIBY) is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The Company is led by Dato' Maznah Binti Abdul Jalil, Liberty's Chief Executive Officer, and Dato' Khalid bin Hj Ahmad, Liberty's Chief Financial Officer. Liberty is sponsored by Liberty Fields, LLC. For more information visit the company's website at:

Limbach Holdings Corp. (NASDAQ: LMB)

Limbach Holdings Corp. (NASDAQ: LMB) is a building systems solutions firm with expertise in the design, prefabrication, installation, management and maintenance of heating, ventilation, air-conditioning ("HVAC"), mechanical, electrical, plumbing and controls systems. With over 1,500 team members and 17 offices located throughout the United States, we partner with institutions with mission-critical infrastructures, such as data centers and healthcare, industrial & light manufacturing, cultural & entertainment, higher education, and life science facilities. With Limbach's full life-cycle capabilities, from concept design and engineering through system commissioning and recurring 24/7 service and maintenance, Limbach is positioned as a value-added and indispensable partner for building owners, construction managers, general contractors, and energy service companies. For more information visit the company's website at:

Lion Group Holding Ltd. (NASDAQ: LGHL)

Lion Group Holding LTD. (NASDAQ: LGHL) operates an all-in one, state-of-the-art trading platform that offer a wide spectrum of products and services, including (i) Total Return Service (TRS) Trading, (ii) Contract-for-difference (CFD) trading, (iii) Insurance Brokerage and (iv) Futures and Securities Brokerage. In addition, Lion owns a professional and experienced SPAC sponsorship team to become a leader in the SPAC arena, helping guide private companies through their listing journey while creating value for Lion itself. Lion is also committed to building the world's top one-stop, cross-chain, high-expansion non-fungible token (NFT) marketplace as well as operating and managing innovative projects in areas such as the Metaverse, Web 3.0, and ESG through advanced technology research and development. For more information visit the company's website at:

Longeveron Inc. (NASDAQ: LGVN)

Longeveron Inc. (NASDAQ: LGVN) is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company's lead investigational product is Lomecel-B™, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B™ has a multi-modal mechanism of action that is pro-vascular, pro-regenerative, and anti-inflammatory, promoting tissue repair and healing with broad potential applications across a spectrum of disease areas. Longeveron is advancing Lomecel-B™ through clinical trials in three indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's Disease, and Aging Frailty. For more information visit the company's website at:

Luxfer Holdings PLC (NYSE: LXFR)

Luxfer Holdings PLC (NYSE: LXFR) is a global industrial company innovating niche applications in materials engineering. Using its broad array of proprietary technologies, Luxfer focuses on value creation, customer satisfaction, and demanding applications where technical know-how and manufacturing expertise combine to deliver a superior product. Luxfers high-performance materials, components, and high-pressure gas containment devices are used in defense and emergency response, clean energy, healthcare, transportation, and general industrial applications. For more information visit the company's website at:

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717